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Lights, camera, fly eyes
Components of the invertebrate phototransduction cascade 
are localized with rhodopsin in microvilli to form a light-guid-
ing, rod-shaped stack. Light activates a heterotrimeric gua-
nine nucleotide–binding protein (Gq protein) and ultimately 
activates phospholipase C (PLC), which hydrolyzes the minor 
membrane lipid phosphatidylinositol 4,5-biphosphate (PIP2) 
and leads to activation of the prototypical transient receptor 
potential (TRP) and TRP-like channels via an unknown mecha-
nism. Hardie and Franze recently demonstrated that light flash-
es induced rapid contractions in Drosophila photoreceptors 
and that these contractions required PLC activity and resulted 
from hydrolysis of PIP2. Furthermore, light exposure altered 
the activity of mechanosensitive channels in the photoreceptor 
cells. Amphipathic compounds that alter the lipid bilayer prop-
erties inhibited this response. These findings indicate that the 
effects of PIP2 depletion are mediated by mechanical changes 
to the physical properties of the lipid bilayer and suggest that 
mechanical force is a second messenger in metabotropic signal 
transduction. (Science 338:260–3, 2012) Selected by E. Lerner
Reversible immunoediting
Adoptive cell transfer therapies (ACTs) with cytotoxic T cells that 
target melanocyte antigens have been useful to reinforce cellular 
antitumor immunity in cases of metastatic melanoma; however, 
tumors often relapse after a period of remission as a result of 
acquired resistance to T-cell therapy. In a recent study, Landsberg 
and colleagues reported that in a genetically engineered mouse 
melanoma model that mimics tumor regression, remission, and 
relapse, acquired therapy resistance involved reversible down-
regulation of antigen expression in response to T cell–driven 
inflammation. In addition, a switch to a mesenchymal pheno-
type occurred in this inflammatory microenvironment. A similar 
mechanism was detected in human melanoma cells, supporting 
the clinical relevance of these findings. Thus, reversible dedif-
ferentiation of melanoma cells in response to the T cell–medi-
ated inflammatory microenvironment is a novel mechanism of 
immunoediting that leads to ACT resistance because immune 
cells in the tumor microenvironment reversibly alter the dynam-
ic equilibrium of differentiation of melanoma cells. (Nature 
490:412–6, 2012) Selected by S. Yuspa and T. Schwarz
Portal of entry
Hair in mammals is a protective barrier against physical 
stimuli such as trauma, temperature, and ultraviolet light. An 
immunological role for this structure, however, had not pre-
viously been considered. The association of Langerhans cells 
(LCs) with hair follicles has been documented in both humans 
and mice, but the relevance of this finding remained unclear. 
Nagao and colleagues recently demonstrated that pre-LCs 
arise from monomyeloid precursors that express LysM, quickly 
repopulate the epidermis via the hair follicles, and differentiate 
into true LCs in response to mechanical perturbation or inflam-
mation in mice. These cells were recruited by hair follicle kera-
tinocytes in the infundibulum and isthmus via the production 
of specific chemokines (CCL2 and CCL20). No pre-LC infiltra-
tion was observed in hairless mouse or human skin, indicating 
that hair follicles are a portal of entry for LCs into the epider-
mis and that this structure plays a role in immunity in the skin. 
(Nat Immunol 13:744–52, 2012) Selected by T. Schwarz
Proceed with caution
Commonly, effective interventions in health care provide 
modest, incremental benefits, although very large treatment 
effects are occasionally observed in some trials. Pereira and 
colleagues recently evaluated the frequency and reliability of 
very large effects in medicine. Using the Cochrane Database of 
Systematic Reviews to examine 85,002 forest plots from 3,082 
reviews, the investigators documented that 16% of the plots 
represented nominally significant very large effects. Overall, 
these investigations revealed that most large treatment effects 
are described in small studies. Upon further investigation, the 
effect sizes typically become much smaller and many lose their 
nominal significance. Furthermore, these large effects often per-
tain to laboratory-defined efficacy standards, and large effects 
for mortality are nearly nonexistent. Thus, most large-treatment-
effect estimates should be interpreted with caution because the 
vast majority may represent overestimations. Fortuitously, first 
trials presenting large treatment effects were no less likely to 
have subsequent studies than trials not presenting large effects. 
(JAMA 308:1676–84, 2012) Selected by H. Williams
IL-9 for immunotherapy
Recently, immunological targeting of melanoma has become 
the focus of extensive research. In an effort to probe the 
function of the T helper type 17 (Th17) pathway genes 
encoding retinoid-related orphan receptor-γ and IL-23 
receptor (IL-23R), Purwar and colleagues examined mice 
deficient in these factors and found greater growth inhibition 
of subcutaneous B16F10 melanomas compared with that in 
wild-type mice and higher expression of IL-9. In addition, Th9 
cells inhibited tumor growth in mice via an IL-9-dependent 
mechanism. These investigators also identified memory Th9 
cells in healthy human blood and skin samples as well as 
in metastatic melanoma lesions, albeit at lower levels than 
in healthy tissues. Significantly, treatment of tumor-bearing 
mice with recombinant IL-9 inhibited tumor growth. Together, 
these findings offer a potential avenue for clinical treatment 
of melanoma and possibly other tumor types via strategies 
that favor the generation of IL-9-mediated immune responses. 
(Nat Med 18:1248–53, 2012) Selected by B.A. Gilchrest
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